Publication Date
4-19-2023
Document Type
Editorial
Publication Title
Expert Opinion on Drug Safety
DOI
10.1080/14740338.2023.2203488
Keywords
biomedical research/*standards, drug-related side effects and adverse reactions, Epidemiologic research design, evidence-based medicine/*standards
Department
Public Health and Recreation
Recommended Citation
B. Burt Gerstman. "There is no single gold standard study design (RCTs are not the gold standard)" Expert Opinion on Drug Safety (2023). https://doi.org/10.1080/14740338.2023.2203488
Comments
This is an Accepted Manuscript of an article published by Taylor & Francis in Expert Opinion on Drug Safety on 19 Apr 2023, available online: http://www.tandfonline.com/10.1080/14740338.2023.2203488